SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Rat dog micro-cap picks--now moderated

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bucky Katt who wrote (1219)11/24/2004 10:04:24 AM
From: Bucky Katt  Read Replies (3) of 1338
 
FDA Okays Every Drug Pending Approval, Takes Rest Of Year Off
ROCKVILLE, MD—Commissioner Lester M. Crawford of the Food and Drug Administration announced Monday that the FDA has cleared all 314 drugs pending approval—from Avoxildon to Zofax KB—and plans to take the remainder of the year off. "Hmm, 'Monozyklin... a selective serotonin re-uptake inhibitor... may cause irregular heart murmur'... That sounds reasonable," Crawford said, reading the drugs' intended uses from a checklist. "I'm sure Merck wouldn't have bothered making this if it didn't actually work. Approved!" Crawford said he'll use the rest of November to research his month-long Christmas travel plans. Lol.....

theonion.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext